• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳性菌中奥昔康唑和其他喹诺酮类药物的摄取。

Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria.

机构信息

Institute of Global Health of Barcelona, 08036 Barcelona, Spain.

ABAC Therapeutics, 08950 Barcelona, Spain.

出版信息

Int J Mol Sci. 2021 Dec 12;22(24):13363. doi: 10.3390/ijms222413363.

DOI:10.3390/ijms222413363
PMID:34948159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8708121/
Abstract

The big problem of antimicrobial resistance is that it requires great efforts in the design of improved drugs which can quickly reach their target of action. Studies of antibiotic uptake and interaction with their target it is a key factor in this important challenge. We investigated the accumulation of ozenoxacin (OZN), moxifloxacin (MOX), levofloxacin (LVX), and ciprofloxacin (CIP) into the bacterial cells of 5 species, including (SA4-149), (SEP7602), (SPY165), (SAG146), and (EF897) previously characterized.The concentration of quinolone uptake was estimated by agar disc-diffusion bioassay. Furthermore, we determined the inhibitory concentrations 50 (IC) of OZN, MOX, LVX, and CIP against type II topoisomerases from .The accumulation of OZN inside the bacterial cell was superior in comparison to MOX, LVX, and CIP in all tested species. The accumulation of OZN inside the bacterial cell was superior in comparison to MOX, LVX, and CIP in all tested species. The rapid penetration of OZN into the cell was reflected during the first minute of exposure with antibiotic values between 190 and 447 ng/mg (dry weight) of bacteria in all strains. Moreover, OZN showed the greatest inhibitory activity among the quinolones tested for both DNA gyrase and topoisomerase IV isolated from with IC50 values of 10 and 0.5 mg/L, respectively. OZN intracellular concentration was significantly higher than that of MOX, LVX and CIP. All of these features may explain the higher in vitro activity of OZN compared to the other tested quinolones.

摘要

抗菌药物耐药性的一个大问题是,需要投入大量精力来设计能够快速达到作用靶点的改良药物。抗生素摄取及其与靶点相互作用的研究是应对这一重大挑战的关键因素。我们研究了奥扎诺星(OZN)、莫西沙星(MOX)、左氧氟沙星(LVX)和环丙沙星(CIP)在 5 个细菌物种中的积累,包括(SA4-149)、(SEP7602)、(SPY165)、(SAG146)和(EF897)。喹诺酮摄取浓度通过琼脂盘扩散生物测定法进行估计。此外,我们还测定了 OZN、MOX、LVX 和 CIP 对 型拓扑异构酶 II 的抑制浓度 50(IC)。与 MOX、LVX 和 CIP 相比,OZN 在所有测试的物种中都能更好地进入细菌细胞内。与 MOX、LVX 和 CIP 相比,OZN 在所有测试的物种中都能更好地进入细菌细胞内。OZN 在接触抗生素的第一分钟内迅速渗透到细胞内,抗生素值在所有菌株中分别为 190 至 447ng/mg(干重)。此外,OZN 对从 中分离的 DNA 回旋酶和拓扑异构酶 IV 显示出所有测试的喹诺酮类药物中最大的抑制活性,IC50 值分别为 10 和 0.5mg/L。OZN 的细胞内浓度明显高于 MOX、LVX 和 CIP。所有这些特征都可以解释 OZN 与其他测试的喹诺酮类药物相比具有更高的体外活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/84015bb6a683/ijms-22-13363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/a15f5bf65a68/ijms-22-13363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/3a8aecd63271/ijms-22-13363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/84015bb6a683/ijms-22-13363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/a15f5bf65a68/ijms-22-13363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/3a8aecd63271/ijms-22-13363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120e/8708121/84015bb6a683/ijms-22-13363-g003.jpg

相似文献

1
Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria.阳性菌中奥昔康唑和其他喹诺酮类药物的摄取。
Int J Mol Sci. 2021 Dec 12;22(24):13363. doi: 10.3390/ijms222413363.
2
Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.金黄色葡萄球菌中外排泵基因 mepA 和 norA 过表达株中奥沙沙星与其他喹诺酮类药物的比较活性。
Int J Antimicrob Agents. 2020 Sep;56(3):106082. doi: 10.1016/j.ijantimicag.2020.106082. Epub 2020 Jul 10.
3
Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis.奥扎诺星对耐/敏感金黄色葡萄球菌和表皮葡萄球菌的突变预防浓度。
PLoS One. 2019 Oct 9;14(10):e0223326. doi: 10.1371/journal.pone.0223326. eCollection 2019.
4
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.在体外筛选对奥扎诺星耐药的突变体与左氧氟沙星和环丙沙星在革兰阳性球菌。
J Antimicrob Chemother. 2015 Jan;70(1):57-61. doi: 10.1093/jac/dku375. Epub 2014 Sep 25.
5
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.奥扎沙星对从日本临床皮肤标本中分离出的甲氧西林敏感金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌和化脓性链球菌的体外抗菌活性。
J Infect Chemother. 2016 Oct;22(10):720-3. doi: 10.1016/j.jiac.2016.03.006. Epub 2016 Apr 16.
6
Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.gyrA 基因突变在氟喹诺酮类耐药幽门螺杆菌菌株中的分布。
World J Gastroenterol. 2010 May 14;16(18):2272-7. doi: 10.3748/wjg.v16.i18.2272.
7
Ozenoxacin: a review of preclinical and clinical efficacy.奥昔沙星:临床前和临床疗效评价。
Expert Rev Anti Infect Ther. 2019 Mar;17(3):159-168. doi: 10.1080/14787210.2019.1573671. Epub 2019 Feb 11.
8
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.奥扎诺星对耐喹诺酮和敏感的革兰阳性菌的体外活性。
Antimicrob Agents Chemother. 2013 Dec;57(12):6389-92. doi: 10.1128/AAC.01509-13. Epub 2013 Sep 30.
9
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.唑诺沙星对革兰阳性临床分离菌的体外抗菌活性比较。
Future Microbiol. 2018 May 1;13:3-19. doi: 10.2217/fmb-2017-0289.
10
Microbiological profile of ozenoxacin.肟沙星的微生物分析。
Future Microbiol. 2019 Jun;14:773-787. doi: 10.2217/fmb-2019-0089. Epub 2019 May 28.

引用本文的文献

1
QbD Based Formulation Development and Optimisation of Ozenoxacin Topical Nano-Emulgel and Efficacy Evaluation Using Impetigo Mice Model.基于 QbD 的奥青纳米乳剂的制剂开发和优化及在脓疱疮小鼠模型中的疗效评价。
AAPS PharmSciTech. 2024 Apr 22;25(5):90. doi: 10.1208/s12249-024-02805-x.
2
Green Nail Syndrome Treated with Ozenoxacin: Two Case Reports.用奥扎沙星治疗绿甲综合征:两例报告
Case Rep Dermatol. 2023 Nov 16;15(1):217-224. doi: 10.1159/000533923. eCollection 2023 Jan-Dec.
3
Fluoroquinolone-Associated Movement Disorder: A Literature Review.

本文引用的文献

1
Fast bacterial growth reduces antibiotic accumulation and efficacy.快速的细菌生长会降低抗生素的积累和疗效。
Elife. 2022 Jun 7;11:e74062. doi: 10.7554/eLife.74062.
2
Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system.全身用喹诺酮类药物与视网膜脱离风险 I:美国 FDA 不良事件报告系统数据分析。
Expert Opin Drug Saf. 2022 Feb;21(2):269-276. doi: 10.1080/14740338.2022.1993187. Epub 2021 Oct 24.
3
Fluorescent macrolide probes - synthesis and use in evaluation of bacterial resistance.
氟喹诺酮类药物相关运动障碍:文献综述
Medicines (Basel). 2023 May 25;10(6):33. doi: 10.3390/medicines10060033.
4
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives.纳米技术在治疗呼吸道感染方面的新兴策略:实现当前趋势,展望未来临床应用。
Drug Deliv. 2022 Dec;29(1):2442-2458. doi: 10.1080/10717544.2022.2089294.
荧光大环内酯类探针——合成及其在细菌耐药性评估中的应用
RSC Chem Biol. 2020 Nov 17;1(5):395-404. doi: 10.1039/d0cb00118j. eCollection 2020 Dec 1.
4
Towards the sustainable discovery and development of new antibiotics.迈向新型抗生素的可持续发现与开发。
Nat Rev Chem. 2021;5(10):726-749. doi: 10.1038/s41570-021-00313-1. Epub 2021 Aug 19.
5
The Whole Is Bigger than the Sum of Its Parts: Drug Transport in the Context of Two Membranes with Active Efflux.整体大于部分之和:两膜中主动外排的药物转运
Chem Rev. 2021 May 12;121(9):5597-5631. doi: 10.1021/acs.chemrev.0c01137. Epub 2021 Feb 17.
6
Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.金黄色葡萄球菌中外排泵基因 mepA 和 norA 过表达株中奥沙沙星与其他喹诺酮类药物的比较活性。
Int J Antimicrob Agents. 2020 Sep;56(3):106082. doi: 10.1016/j.ijantimicag.2020.106082. Epub 2020 Jul 10.
7
Single-cell microfluidics facilitates the rapid quantification of antibiotic accumulation in Gram-negative bacteria.单细胞微流控技术有助于快速定量革兰氏阴性菌中抗生素的积累。
Lab Chip. 2020 Aug 7;20(15):2765-2775. doi: 10.1039/d0lc00242a. Epub 2020 Jul 2.
8
Quinolone antibiotics.喹诺酮类抗生素
Medchemcomm. 2019 Jun 28;10(10):1719-1739. doi: 10.1039/c9md00120d. eCollection 2019 Oct 1.
9
Microbiological profile of ozenoxacin.肟沙星的微生物分析。
Future Microbiol. 2019 Jun;14:773-787. doi: 10.2217/fmb-2019-0089. Epub 2019 May 28.
10
Ozenoxacin: a review of preclinical and clinical efficacy.奥昔沙星:临床前和临床疗效评价。
Expert Rev Anti Infect Ther. 2019 Mar;17(3):159-168. doi: 10.1080/14787210.2019.1573671. Epub 2019 Feb 11.